as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹118.73
Change
+1.91 (1.63%)
Open
₹115.65
Prev. Close
₹116.82
Day High
₹118.89
Day Low
₹115.65
Volume Analysis
Traded
842,219
Delivered
597,153
Delivery %
70.9%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹123.11 | ₹121.0 | ₹119.87 | ₹117.76 | ₹116.63 | ₹114.52 | ₹113.39 |
| Fibonacci | ₹121.0 | ₹119.76 | ₹119.0 | ₹117.76 | ₹116.52 | ₹115.76 | ₹114.52 |
| Camarilla | ₹119.62 | ₹119.32 | ₹119.03 | ₹117.76 | ₹118.43 | ₹118.14 | ₹117.84 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+1.08%
1 Week
+1.91%
1 Month
+11.37%
3 Months
+2.99%
6 Months
-1.39%
1 Year
+1.14%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Icicipramc - Bharatiwin holds up reasonably well on TopFund's composite fundamentals check, at 72/100. The strongest factor is Liquidity (74/100), while Risk & Volatility (70/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
72/100 — GoodData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Which Mutual Funds Hold Icicipramc - Bharatiwin?
Frequently Asked Questions about Icicipramc - Bharatiwin
Icicipramc - Bharatiwin (ICICIB22) closed at ₹118.73 on NSE on 19 November 2026, up 1.91 (1.63%) from the previous close.
Icicipramc - Bharatiwin trades on the NSE (National Stock Exchange of India) under the symbol ICICIB22.
Icicipramc - Bharatiwin has a TopFund Quality Score of 72/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Icicipramc - Bharatiwin?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.